Literature DB >> 21497175

Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes.

Anne Schlegel1, Céline Largeau, Pascal Bigey, Michel Bessodes, Kristell Lebozec, Daniel Scherman, Virginie Escriou.   

Abstract

We recently reported a cationic lipid-based vector of siRNA, termed siRNA lipoplex that was very efficient in specific gene silencing, both in cell culture and in mouse disease models. To be more efficient, this vector included the addition of a plasmid DNA as an anionic "cargo." Although this plasmid DNA was devoid of any eukaryotic expression cassette, we decided to replace it by an anionic polymer that would be more acceptable for clinical applications. We identified seven anionic polymers, regarded as non-toxic, biodegradable, of various characteristics and nature. The addition of polymers to siRNA lipoplexes led to the formation of particles with similar characteristics to crude siRNA lipoplexes, decreased cellular toxicity and variable in vitro gene silencing efficiency depending on the type of polymer used. Upon i.v. injection in mice, siRNA lipoplexes prepared with the best polymer, polyglutamate, led to significantly increased recovery of siRNA in liver and lung compared with lipoplexes without polymer.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21497175     DOI: 10.1016/j.jconrel.2011.03.031

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  20 in total

1.  Anionic Polymer and Quantum Dot Excipients to Facilitate siRNA Release and Self-Reporting of Disassembly in Stimuli-Responsive Nanocarrier Formulations.

Authors:  Chad T Greco; Jason C Andrechak; Thomas H Epps; Millicent O Sullivan
Journal:  Biomacromolecules       Date:  2017-05-10       Impact factor: 6.988

2.  Junctional neurulation: a unique developmental program shaping a discrete region of the spinal cord highly susceptible to neural tube defects.

Authors:  Alwyn Dady; Emmanuelle Havis; Virginie Escriou; Martin Catala; Jean-Loup Duband
Journal:  J Neurosci       Date:  2014-09-24       Impact factor: 6.167

Review 3.  siRNA delivery to the lung: what's new?

Authors:  Olivia M Merkel; Israel Rubinstein; Thomas Kissel
Journal:  Adv Drug Deliv Rev       Date:  2014-06-05       Impact factor: 15.470

Review 4.  Therapeutic potential of siRNA and DNAzymes in cancer.

Authors:  Hanuma Kumar Karnati; Ravi Shekar Yalagala; Rambabu Undi; Satya Ratan Pasupuleti; Ravi Kumar Gutti
Journal:  Tumour Biol       Date:  2014-08-23

5.  MicroRNA Targets for Asthma Therapy.

Authors:  Sabrina C Ramelli; William T Gerthoffer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery.

Authors:  Jiangbing Zhou; Jie Liu; Christopher J Cheng; Toral R Patel; Caroline E Weller; Joseph M Piepmeier; Zhaozhong Jiang; W Mark Saltzman
Journal:  Nat Mater       Date:  2011-12-04       Impact factor: 43.841

Review 7.  Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines.

Authors:  Jinho Park; Joonyoung Park; Yihua Pei; Jun Xu; Yoon Yeo
Journal:  Adv Drug Deliv Rev       Date:  2015-12-10       Impact factor: 15.470

8.  Attenuation of Maladaptive Responses in Aortic Adventitial Fibroblasts through Stimuli-Triggered siRNA Release from Lipid-Polymer Nanocomplexes.

Authors:  Chad T Greco; Robert E Akins; Thomas H Epps; Millicent O Sullivan
Journal:  Adv Biosyst       Date:  2017-07-20

Review 9.  siRNA-based therapeutic approaches for rheumatic diseases.

Authors:  Florence Apparailly; Christian Jorgensen
Journal:  Nat Rev Rheumatol       Date:  2012-10-23       Impact factor: 20.543

10.  Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief.

Authors:  Dane D Jensen; TinaMarie Lieu; Michelle L Halls; Nicholas A Veldhuis; Wendy L Imlach; Quynh N Mai; Daniel P Poole; Tim Quach; Luigi Aurelio; Joshua Conner; Carmen Klein Herenbrink; Nicholas Barlow; Jamie S Simpson; Martin J Scanlon; Bimbil Graham; Adam McCluskey; Phillip J Robinson; Virginie Escriou; Romina Nassini; Serena Materazzi; Pierangelo Geppetti; Gareth A Hicks; Macdonald J Christie; Christopher J H Porter; Meritxell Canals; Nigel W Bunnett
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.